Loading company…
Ventuno Biotech develops immunotherapies for cancer, including difficult-to-treat tumors.
Founded in 2025 and based in Lyon, France, Ventuno Biotech develops cancer immunotherapies intended to strengthen the immune response against tumors. It raised EUR 2 million in Seed funding in November 2025, led by OCTALFA with Turenne Groupe participating. The funding will support discovery and translational research and preclinical work on its lead assets.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in